Cargando…

Basolateral activation with TLR agonists induces polarized cytokine release and reduces barrier function in RPE in vitro

PURPOSE: Systemic inflammation may be of importance in the development of AMD. RPE cells can recognize danger signals with toll-like receptors (TLR) and may react in a pro-inflammatory manner. In this study, we evaluated the basal and apical secretions of TNFα, IL-6, and IL-1β in primary RPE cells a...

Descripción completa

Detalles Bibliográficos
Autores principales: Terheyden, Laura, Roider, Johann, Klettner, Alexa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843481/
https://www.ncbi.nlm.nih.gov/pubmed/32949301
http://dx.doi.org/10.1007/s00417-020-04930-2
_version_ 1783644155062255616
author Terheyden, Laura
Roider, Johann
Klettner, Alexa
author_facet Terheyden, Laura
Roider, Johann
Klettner, Alexa
author_sort Terheyden, Laura
collection PubMed
description PURPOSE: Systemic inflammation may be of importance in the development of AMD. RPE cells can recognize danger signals with toll-like receptors (TLR) and may react in a pro-inflammatory manner. In this study, we evaluated the basal and apical secretions of TNFα, IL-6, and IL-1β in primary RPE cells and RPE/choroid explant cells under basolateral stimulation of TLR2, 3, and 4; the effects on barrier function; and their influence on neuronal cell viability. METHODS: RPE/choroid tissue explants were prepared from porcine eyes and cultivated in modified Ussing chambers; primary porcine RPE cells on transwell plates. Cells were basally stimulated with agonists Pam2CSK4 (Pam; TLR2), polyinosinic/polycytidylic acid (Poly I:C; TLR3), and lipopolysaccharide (LPS; TLR4) for 24 h. Supernatants were evaluated with ELISA for cytokines TNFα, IL-6, and IL-1β. Apical supernatants were applied to SHSY-5Y cells, and cell viability was evaluated in MTT assay. Barrier function was tested by measuring transepithelial electrical resistance (TER) and occludin immunostaining. RESULTS: None of the tested TLR agonists was toxic on RPE cells after 24 h of exposure. Unstimulated RPE cells secreted hardly any cytokines. Pam induced IL-6, IL-1ß, and TNFα on the basal and apical sides at all concentrations tested. Poly I:C induced IL-6 and TNFα primarily at the basal side at lower but on both sides at higher concentrations. LPS induced IL-6, IL-1ß, and TNFα apically and basally at all concentrations tested. In the RPE/choroid, a strong difference between apical and basal secretions could be found. IL-6 was constitutively secreted basally, but not apically, but was induced by all agonists on both sides. IL-1ß and TNFα alpha were strongly induced on the basal side by all agonists. TER was reduced by all agonists, with Pam and LPS being effective in all concentrations tested. Occludin expression was unaltered, but the distribution was influenced by the agonists, with a less distinct localization at the cell borders after treatment. None of the agonists or supernatants of treated RPE and RPE/choroid organ cultures exerted any effect on viability of SHSY-5Y cells. CONCLUSIONS: Danger signals activating TLRs can induce polarized cytokine expression and contribute to the loss of barrier function in the RPE.
format Online
Article
Text
id pubmed-7843481
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-78434812021-02-04 Basolateral activation with TLR agonists induces polarized cytokine release and reduces barrier function in RPE in vitro Terheyden, Laura Roider, Johann Klettner, Alexa Graefes Arch Clin Exp Ophthalmol Basic Science PURPOSE: Systemic inflammation may be of importance in the development of AMD. RPE cells can recognize danger signals with toll-like receptors (TLR) and may react in a pro-inflammatory manner. In this study, we evaluated the basal and apical secretions of TNFα, IL-6, and IL-1β in primary RPE cells and RPE/choroid explant cells under basolateral stimulation of TLR2, 3, and 4; the effects on barrier function; and their influence on neuronal cell viability. METHODS: RPE/choroid tissue explants were prepared from porcine eyes and cultivated in modified Ussing chambers; primary porcine RPE cells on transwell plates. Cells were basally stimulated with agonists Pam2CSK4 (Pam; TLR2), polyinosinic/polycytidylic acid (Poly I:C; TLR3), and lipopolysaccharide (LPS; TLR4) for 24 h. Supernatants were evaluated with ELISA for cytokines TNFα, IL-6, and IL-1β. Apical supernatants were applied to SHSY-5Y cells, and cell viability was evaluated in MTT assay. Barrier function was tested by measuring transepithelial electrical resistance (TER) and occludin immunostaining. RESULTS: None of the tested TLR agonists was toxic on RPE cells after 24 h of exposure. Unstimulated RPE cells secreted hardly any cytokines. Pam induced IL-6, IL-1ß, and TNFα on the basal and apical sides at all concentrations tested. Poly I:C induced IL-6 and TNFα primarily at the basal side at lower but on both sides at higher concentrations. LPS induced IL-6, IL-1ß, and TNFα apically and basally at all concentrations tested. In the RPE/choroid, a strong difference between apical and basal secretions could be found. IL-6 was constitutively secreted basally, but not apically, but was induced by all agonists on both sides. IL-1ß and TNFα alpha were strongly induced on the basal side by all agonists. TER was reduced by all agonists, with Pam and LPS being effective in all concentrations tested. Occludin expression was unaltered, but the distribution was influenced by the agonists, with a less distinct localization at the cell borders after treatment. None of the agonists or supernatants of treated RPE and RPE/choroid organ cultures exerted any effect on viability of SHSY-5Y cells. CONCLUSIONS: Danger signals activating TLRs can induce polarized cytokine expression and contribute to the loss of barrier function in the RPE. Springer Berlin Heidelberg 2020-09-19 2021 /pmc/articles/PMC7843481/ /pubmed/32949301 http://dx.doi.org/10.1007/s00417-020-04930-2 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Basic Science
Terheyden, Laura
Roider, Johann
Klettner, Alexa
Basolateral activation with TLR agonists induces polarized cytokine release and reduces barrier function in RPE in vitro
title Basolateral activation with TLR agonists induces polarized cytokine release and reduces barrier function in RPE in vitro
title_full Basolateral activation with TLR agonists induces polarized cytokine release and reduces barrier function in RPE in vitro
title_fullStr Basolateral activation with TLR agonists induces polarized cytokine release and reduces barrier function in RPE in vitro
title_full_unstemmed Basolateral activation with TLR agonists induces polarized cytokine release and reduces barrier function in RPE in vitro
title_short Basolateral activation with TLR agonists induces polarized cytokine release and reduces barrier function in RPE in vitro
title_sort basolateral activation with tlr agonists induces polarized cytokine release and reduces barrier function in rpe in vitro
topic Basic Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843481/
https://www.ncbi.nlm.nih.gov/pubmed/32949301
http://dx.doi.org/10.1007/s00417-020-04930-2
work_keys_str_mv AT terheydenlaura basolateralactivationwithtlragonistsinducespolarizedcytokinereleaseandreducesbarrierfunctioninrpeinvitro
AT roiderjohann basolateralactivationwithtlragonistsinducespolarizedcytokinereleaseandreducesbarrierfunctioninrpeinvitro
AT klettneralexa basolateralactivationwithtlragonistsinducespolarizedcytokinereleaseandreducesbarrierfunctioninrpeinvitro